Anterior Uveitis Caused by Ocular Side Effects of Afatinib: A Case Report

Afatinib is a second-generation epidermal growth factor receptor (EGFR) inhibitor that has been shown to be effective against EGFR-mutated non-small cell lung cancer (NSCLC) resistant to conventional EGFR inhibitors such as gefitinib and erlotinib. Although ocular side effects of gefitinib and erlot...

Full description

Bibliographic Details
Main Authors: Daisuke Todokoro, Hirotaka Itakura, Takashi Ibe, Shoji Kishi
Format: Article
Language:English
Published: Karger Publishers 2016-02-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/444047